Polymorphisms in advanced glycosylation end product-specific receptor (AGER) gene, insulin resistance, and type 2 diabetes mellitus

Clinica Chimica Acta

Volumn 398, Issue 1-2, 2008, Pages 95-98

  Goulart, A C ^a   Germer, S ^b   Rexrode, K M ^a   Martin, M ^b   Zee, R Y L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

Author keywords

Advanced glycosylation end product specific receptor; Genetic polymorphism; Type 2 diabetes mellitus

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PATHOGENESIS; PRIORITY JOURNAL; RACE DIFFERENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; BODY MASS INDEX; BOSTON; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLUCOSE TOLERANCE TEST; HAPLOTYPES; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RECEPTORS, IMMUNOLOGIC; REGRESSION ANALYSIS;

EID: 54049137548     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.08.020     Document Type: Article

References (23)

1. Baynes J.W., and Thorpe S.R. Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 28 (2000) 1708-1716
2. Kalousova M., Zima T., Tesar V., Dusilova-Sulkova S., and Skrha J. Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. Mutat Res 579 (2005) 37-46
3. Bierhaus A., Hofmann M.A., Ziegler R., and Nawroth P.P. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res 37 (1998) 586-600
4. Sullivan C.M., Futers T.S., Barrett J.H., Hudson B.I., Freeman M.S., and Grant P.J. RAGE polymorphisms and the heritability of insulin resistance: the Leeds family study. Diab Vasc Dis Res 2 (2005) 42-44
5. Newfield R.S., Polak M., Marchase R., and Czernichow P. Epidemiology and genetics of diabetic complications. Diabetologia 40 Suppl 3 (1997) B62-B64
6. Pettersson-Fernholm K., Forsblom C., Hudson B.I., Perola M., Grant P.J., and Groop P.H. The functional -374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients. Diabetes 52 (2003) 891-894
7. Zee R.Y., Romero J.R., Gould J.L., Ricupero D.A., and Ridker P.M. Polymorphisms in the advanced glycosylation end product-specific receptor gene and risk of incident myocardial infarction or ischemic stroke. Stroke 37 (2006) 1686-1690
8. dos Santos K.G., Canani L.H., Gross J.L., Tschiedel B., Pires Souto K.E., and Roisenberg I. The -374A allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic heart disease in African-Brazilians with type 2 diabetes. Mol Genet Metab 85 (2005) 149-156
9. Zee R.Y., Germer S., Thomas A., et al. C-reactive protein gene variation and type 2 diabetes mellitus: a case-control study. Atherosclerosis 197 (2008) 931-936
10. Sluiter W.J., Erkelens D.W., Reitsma W.D., and Doorenbos H. Glucose tolerance and insulin release, a mathematical approach I. Assay of the beta-cell response after oral glucose loading. Diabetes 25 (1976) 241-244
11. Sluiter W.J., Erkelens D.W., Terpstra P., Reitsma W.D., and Doorenbos H. Glucose tolerance and insulin release, a mathematical approach. II. Approximation of the peripheral insulin resistance after oral glucose loading. Diabetes 25 (1976) 245-249
12. Hanson R.L., Pratley R.E., Bogardus C., et al. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 151 (2000) 190-198
13. Wang J., Chuang K., Ahluwalia M., et al. High-throughput SNP genotyping by single-tube PCR with Tm-shift primers. Biotechniques 39 (2005) 885-893
14. Devlin B., and Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 29 (1995) 311-322
15. Stephens M., and Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73 (2003) 1162-1169
16. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68 (2001) 978-989
17. Wallenstein S., Hodge S.E., and Weston A. Logistic regression model for analyzing extended haplotype data. Genet Epidemiol 15 (1998) 173-181
18. Hudson B.I., Stickland M.H., and Grant P.J. Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups. Diabetes 47 (1998) 1155-1157
19. Kankova K., Stejskalova A., Hertlova M., and Znojil V. Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus. Nephrol Dial Transplant 20 (2005) 1093-1102
20. Kankova K., Vasku A., Hajek D., Zahejsky J., and Vasku V. Association of G82S polymorphism in the RAGE gene with skin complications in type 2 diabetes. Diabetes Care 22 (1999) 1745
21. Picheth G., Heidemann M., Pedrosa F.O., et al. The - 429 T > C polymorphism of the receptor for advanced glycation end products (RAGE) is associated with type 1 diabetes in a Brazilian population. Clin Chim Acta 383 (2007) 163-164
22. Laki J., Kiszel P., Vatay A., et al. The HLA 8.1 ancestral haplotype is strongly linked to the C allele of - 429T > C promoter polymorphism of receptor of the advanced glycation endproduct (RAGE) gene. Haplotype-independent association of the - 429C allele with high hemoglobinA1C levels in diabetic patients. Mol Immunol 44 (2007) 648-655
23. Naka C.L., Picheth G., Alcantera V.M., et al. The Gly82Ser polymorphism of the receptor of advanced glycation end product (RAGE) gene is not associated with type 1 or type 2 diabetes in a Brazilian population. Diabetes Care 29 (2006) 712-713